These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8792437)

  • 1. Investigations into the relationship between drug properties, filling, and the release of drugs from hard gelatin capsules using multivariate statistical analysis.
    Hogan J; Shue PI; Podczeck F; Newton JM
    Pharm Res; 1996 Jun; 13(6):944-9. PubMed ID: 8792437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro bioavailability of various drugs formulated as hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 Apr; 29(4):205-8. PubMed ID: 17668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of drug and diluent particle size on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1980 Mar; 32(3):167-71. PubMed ID: 6103930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of additives on the presentation of a drug in hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of statistical analysis and Bayesian Networks in the evaluation of dissolution performance of BCS Class II model drugs.
    Wilson WI; Peng Y; Augsburger LL
    J Pharm Sci; 2005 Dec; 94(12):2764-76. PubMed ID: 16258987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of disintegrants in hard-gelatin capsules.
    Botzolakis JE; Augsburger LL
    J Pharm Pharmacol; 1984 Feb; 36(2):77-84. PubMed ID: 6143810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Polymer Type on the Physical Properties and Release Profile of Papaverine Hydrochloride From Hard Gelatin Capsules.
    Polski A; Iwaniak K; Kasperek R; Modrzewska J; Sobótka-Polska K; Sławińska K; Poleszak E
    Polim Med; 2015; 45(2):51-5. PubMed ID: 26994886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog.
    Marvola M; Hannula AM; Ojantakanen S; Westermarck E; Rajamäki M
    Acta Pharm Nord; 1989; 1(6):355-62. PubMed ID: 2560378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The influence of formulation variables on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Razzo RN
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():79P. PubMed ID: 2756
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: The interaction of formulation factors and dissolution fluid and the in vitro release of drug from hard gelatin capsules.
    Newton JM; Razzo RN
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():78P. PubMed ID: 2755
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of pH of dissolution fluid and particle size of drug on the in-vitro release of drug from hard gelatin capsules.
    Muhammad NA; Newton JM
    J Pharm Pharmacol; 1983 Jun; 35(6):345-9. PubMed ID: 6135771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.